Qinggang Li

机构：State Administration of Traditional Chinese Medicine of the People's Republic of China, Chinese PLA General Hospital, Suzhou Research Institute, National Clinical Research · ORCID：0000-0002-6623-5975

发表论文 114 篇 · 总被引 2796 次 · h-index 28

代表论文

Insights into new-onset autoimmune diseases after COVID-19 vaccination (2023 · Autoimmunity Reviews · 被引 104)
Targeted therapy of kidney disease with nanoparticle drug delivery materials (2024 · Bioactive Materials · 被引 90)
Combinatorial metabolic engineering and tolerance evolving of Escherichia coli for high production of 2′-fucosyllactose (2023 · Bioresource Technology · 被引 45)
Complement factor B inhibitor LNP023 improves lupus nephritis in MRL/lpr mice (2022 · Biomedicine & Pharmacotherapy · 被引 31)
Azvudine therapy of common COVID‐19 in hemodialysis patients (2023 · Journal of Medical Virology · 被引 27)
Flexible, magnetic and sandwich-structural Fe2O3/CNT/Fe2O3 composite film with absorption-dominant EMI shielding performance (2025 · Journal of Material Science and Technology · 被引 24)